Metraipolis › archive › dc_0b3ba2cc48aa
Medication for opioid use disorder among adolescents entering specialty treatment for opioid use disorder and trends in the US, 2017-2022 — Europe PMC PMID:41202482
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41202482
- DOI
- 10.1016/j.addbeh.2025.108538
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T23:20:18.448Z
- SHA-256 of the archived text
bf9f68b69a40680526e281f047020645e4162b3f3bf537bc37492b21af48faa7- Stable URL of this page
https://metraipolis.com/documento/dc_0b3ba2cc48aa
How to cite
Medication for opioid use disorder among adolescents entering specialty treatment for opioid use disorder and trends in the US, 2017-2022 — Europe PMC PMID:41202482 — Europe PMC (en), https://europepmc.org/article/MED/41202482 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0b3ba2cc48aa (Metraipolis archive dc_0b3ba2cc48aa, sha256 bf9f68b69a40680526e281f047020645e4162b3f3bf537bc37492b21af48faa7)
BibTeX
@misc{dc0b3ba2cc48aa,
title = {Medication for opioid use disorder among adolescents entering specialty treatment for opioid use disorder and trends in the US, 2017-2022 — Europe PMC PMID:41202482},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41202482},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0b3ba2cc48aa; sha256 bf9f68b69a40680526e281f047020645e4162b3f3bf537bc37492b21af48faa7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41202482. Agents can read the archived copy with the MCP tool read_document.